APOSENSE
Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple disease categories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical ... imaging of disease activity and targeted therapy. Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core. Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
APOSENSE
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1996-01-01
Address:
Petah Tiqva, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.aposense.com
Total Employee:
11+
Status:
Active
Contact:
+ 972.73.239.7600
Email Addresses:
[email protected]
Total Funding:
22.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Nginx Microsoft Exchange Online Office 365 Mail Google Maps Google Maps API Typekit
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ziegler Meditech Equity Partners
Ziegler Meditech Equity Partners investment in Venture Round - Aposense
Pontifax
Pontifax investment in Venture Round - Aposense
Pontifax
Pontifax investment in Venture Round - Aposense
Polar Investments
Polar Investments investment in Venture Round - Aposense
Technorov Holdings
Technorov Holdings investment in Venture Round - Aposense
Docor International Management
Docor International Management investment in Venture Round - Aposense
Ziegler Meditech Equity Partners
Ziegler Meditech Equity Partners investment in Venture Round - Aposense
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Venture Round - Aposense
Phoenix Insurance
Phoenix Insurance investment in Venture Round - Aposense
Bargal R&D Investment
Bargal R&D Investment investment in Venture Round - Aposense
Official Site Inspections
http://www.aposense.com Semrush global rank: 9.52 M Semrush visits lastest month: 141
- Host name: mail.aposense.com
- IP address: 185.106.129.182
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
